• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.强化血糖控制与心血管事件预防：ACCORD、ADVANCE及退伍军人糖尿病试验的启示：美国糖尿病协会立场声明及美国心脏病学会基金会与美国心脏协会科学声明
Diabetes Care. 2009 Jan;32(1):187-92. doi: 10.2337/dc08-9026. Epub 2008 Dec 17.
2
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.强化血糖控制与心血管事件预防：ACCORD、ADVANCE及退伍军人事务部糖尿病试验的启示：美国糖尿病协会立场声明及美国心脏病学会基金会和美国心脏协会科学声明
Circulation. 2009 Jan 20;119(2):351-7. doi: 10.1161/CIRCULATIONAHA.108.191305. Epub 2008 Dec 17.
3
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.强化血糖控制与心血管事件预防：ACCORD、ADVANCE及退伍军人事务部糖尿病试验的启示：美国糖尿病协会立场声明以及美国心脏病学会基金会和美国心脏协会科学声明
J Am Coll Cardiol. 2009 Jan 20;53(3):298-304. doi: 10.1016/j.jacc.2008.10.008.
4
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.强化血糖控制与心血管事件预防：ACCORD、ADVANCE及退伍军人糖尿病试验的启示：美国糖尿病协会立场声明及美国心脏病学会基金会和美国心脏协会科学声明：对斯凯勒等人的回应
Diabetes Care. 2009 Jul;32(7):e90-1; author reply e92-3. doi: 10.2337/dc09-9030.
5
[Intensive glycemia control of type-2 diabetes mellitus: a real A(D)VANCe or a deep dis(ACCORD)?].[2型糖尿病强化血糖控制：是真正的进展还是深度的不协调？]
Rev Med Suisse. 2008 Aug 6;4(166):1734.
6
Fasting and post-prandial glucose and diabetic complication. A meta-analysis.空腹和餐后血糖与糖尿病并发症。一项荟萃分析。
Nutr Metab Cardiovasc Dis. 2013 Jul;23(7):591-8. doi: 10.1016/j.numecd.2013.03.007. Epub 2013 May 24.
7
[Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].[糖尿病患者的血压控制。关注餐后血糖值与心血管风险]
MMW Fortschr Med. 2012 Feb 23;154(3):82-3.
8
Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.一篇文章的综述：阿司匹林用于糖尿病患者心血管事件的一级预防。美国糖尿病协会（ADA）的立场声明、美国心脏协会（AHA）的科学声明以及美国心脏病学基金会（ACCF）的专家共识文件。《糖尿病护理》，第33卷，第6期；2010年6月；第1395 - 1402页。
J Vasc Nurs. 2010 Dec;28(4):154-5. doi: 10.1016/j.jvn.2010.10.002.
9
The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes.低血糖在糖尿病心血管结局中的作用。
Can J Diabetes. 2015 Dec;39 Suppl 5:S155-9. doi: 10.1016/j.jcjd.2015.09.009.
10
[Intensive glucose control in type 2 diabetes is beneficial].2型糖尿病强化血糖控制有益。
Lakartidningen. 2009;106(36):2198.

引用本文的文献

1
Recent advances in the prevention of secondary ischemic stroke: A narrative review.继发性缺血性卒中预防的最新进展：一项叙述性综述。
Brain Circ. 2024 Dec 28;10(4):283-295. doi: 10.4103/bc.bc_159_24. eCollection 2024 Oct-Dec.
2
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2025.6. 血糖目标与低血糖：2025年糖尿病照护标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S128-S145. doi: 10.2337/dc25-S006.
3
Post Hoc Analysis of SURPASS-1 to -5: Efficacy and Safety of Tirzepatide in Adults with Type 2 Diabetes are Independent of Baseline Characteristics.SURPASS-1至-5的事后分析：替尔泊肽在2型糖尿病成人患者中的疗效和安全性与基线特征无关。
Diabetes Ther. 2025 Jan;16(1):43-71. doi: 10.1007/s13300-024-01660-0. Epub 2024 Nov 12.
4
Diabetes and the risk of cardiovascular events and all-cause mortality among older adults: an individual participant data analysis of five prospective studies.糖尿病与老年人心血管事件风险及全因死亡率：五项前瞻性研究的个体参与者数据分析
Eur J Clin Invest. 2025 Feb;55(2):e14340. doi: 10.1111/eci.14340. Epub 2024 Oct 28.
5
Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management.血糖控制在2型糖尿病管理的优先事项中仍然处于核心地位。
Diabetologia. 2025 Jan;68(1):17-28. doi: 10.1007/s00125-024-06254-w. Epub 2024 Aug 19.
6
Developing an Exercise Attitudes and Behavior Intentions Questionnaire for Survivors of Aortic Dissection: An Exploratory Factor Analysis.为主动脉夹层幸存者编制运动态度与行为意向问卷：探索性因素分析
Rev Cardiovasc Med. 2022 Oct 11;23(10):337. doi: 10.31083/j.rcm2310337. eCollection 2022 Oct.
7
Type 2 diabetes in children and adolescents: Exploring the disease heterogeneity and research gaps to optimum management.儿童和青少年2型糖尿病：探索疾病异质性及优化管理方面的研究差距
World J Clin Pediatr. 2024 Jun 9;13(2):91587. doi: 10.5409/wjcp.v13.i2.91587.
8
Physical performance strongly predicts all-cause mortality risk in a real-world population of older diabetic patients: machine learning approach for mortality risk stratification.在真实世界中老年糖尿病患者人群中，体能表现可强烈预测全因死亡率风险：用于死亡率风险分层的机器学习方法。
Front Endocrinol (Lausanne). 2024 Apr 30;15:1359482. doi: 10.3389/fendo.2024.1359482. eCollection 2024.
9
Determinants of adherence to insulin and blood glucose monitoring among adolescents and young adults with type 1 diabetes in Qatar: a qualitative study.卡塔尔 1 型糖尿病青少年和年轻成人患者胰岛素和血糖监测依从性的决定因素：一项定性研究。
F1000Res. 2024 Feb 20;11:907. doi: 10.12688/f1000research.123468.2. eCollection 2022.
10
Mediators of Cardiovascular and Renal Outcomes: How Do Novel Diabetes Medications Work?心血管和肾脏结局的介导因素：新型糖尿病药物如何发挥作用？
J Am Heart Assoc. 2024 Feb 20;13(4):e033863. doi: 10.1161/JAHA.124.033863. Epub 2024 Feb 16.

本文引用的文献

1
10-year follow-up of intensive glucose control in type 2 diabetes.2型糖尿病强化血糖控制的10年随访
N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10.
2
Effects of intensive glucose lowering in type 2 diabetes.强化降糖对2型糖尿病的影响。
N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.
3
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.2型糖尿病患者强化血糖控制与血管转归
N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.
4
Effect of a multifactorial intervention on mortality in type 2 diabetes.多因素干预对2型糖尿病患者死亡率的影响。
N Engl J Med. 2008 Feb 7;358(6):580-91. doi: 10.1056/NEJMoa0706245.
5
Standards of medical care in diabetes--2008.2008年糖尿病医疗护理标准
Diabetes Care. 2008 Jan;31 Suppl 1:S12-54. doi: 10.2337/dc08-S012.
6
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.糖尿病患者心血管疾病的一级预防：美国心脏协会和美国糖尿病协会的科学声明
Circulation. 2007 Jan 2;115(1):114-26. doi: 10.1161/CIRCULATIONAHA.106.179294. Epub 2006 Dec 27.
7
Type 1 diabetes and coronary artery disease.1型糖尿病与冠状动脉疾病
Diabetes Care. 2006 Nov;29(11):2528-38. doi: 10.2337/dc06-1161.
8
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.1型和2型糖尿病患者的血糖控制与大血管疾病：随机试验的荟萃分析
Am Heart J. 2006 Jul;152(1):27-38. doi: 10.1016/j.ahj.2005.09.015.
9
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.1型糖尿病患者的强化糖尿病治疗与心血管疾病
N Engl J Med. 2005 Dec 22;353(25):2643-53. doi: 10.1056/NEJMoa052187.
10
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.荟萃分析：糖尿病患者糖化血红蛋白与心血管疾病
Ann Intern Med. 2004 Sep 21;141(6):421-31. doi: 10.7326/0003-4819-141-6-200409210-00007.

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.

作者信息

Skyler Jay S, Bergenstal Richard, Bonow Robert O, Buse John, Deedwania Prakash, Gale Edwin A M, Howard Barbara V, Kirkman M Sue, Kosiborod Mikhail, Reaven Peter, Sherwin Robert S

机构信息

University of Miami, Miami, Florida, USA.

出版信息

Diabetes Care. 2009 Jan;32(1):187-92. doi: 10.2337/dc08-9026. Epub 2008 Dec 17.

DOI:10.2337/dc08-9026
PMID:19092168
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2606812/
Abstract
摘要